BARR LABORATORIES INC
S-3, EX-5.1, 2000-09-14
PHARMACEUTICAL PREPARATIONS
Previous: BARR LABORATORIES INC, S-3, EX-1.1, 2000-09-14
Next: BARR LABORATORIES INC, S-3, EX-23.2, 2000-09-14



<PAGE>   1

                                                                     EXHIBIT 5.1

                        [LETTERHEAD OF WINSTON & STRAWN]

                               September 14, 2000

Barr Laboratories, Inc.
Two Quaker Road
Pomona, New York 10970

     RE: BARR LABORATORIES, INC. (THE "COMPANY")

Ladies and Gentlemen:

     In connection with the Registration Statement on Form S-3 under the
Securities Act of 1933, as amended (the "Registration Statement"), relating to
the offering of 3,500,000 shares, plus up to a maximum of 525,000 additional
shares if the underwriters' over-allotment option is exercised, of Common Stock,
$.01 par value (the "Shares"), of Barr Laboratories, Inc., a New York
corporation (the "Company"), which are to be sold by the Company and a
shareholder of the Company (the "Selling Shareholder"), we have examined such
corporate records and other documents, including the Registration Statement, and
have reviewed such matters of law as we have deemed relevant hereto, and, based
upon this examination and review, it is our opinion that, when issued and sold
as contemplated in the Registration Statement, the Shares offered by the Company
will be legally issued, fully paid and nonassessable and that the outstanding
Shares offered by the Selling Shareholder were legally issued and are fully paid
and nonassessable.

     We hereby consent to the filing of this option as an exhibit to the
Registration Statement and to the use of our name whenever it appears in such
Registration Statement, including the Prospectus constituting a part hereof, as
originally filed or as subsequently amended.

                                          Very truly yours,

                                          /s/ WINSTON & STRAWN

                                          Winston & Strawn

MFM:vjw


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission